Sesamin, a sesame lignan, as a potent serum lipid-lowering food component

被引:19
|
作者
Ide, T [1 ]
Kushiro, M
Takahashi, Y
Shinohara, K
Fukuda, N
Sirato-Yasumoto, S
机构
[1] Natl Food Res Inst, Div Food Funct, Tsukuba, Ibaraki 3058642, Japan
[2] Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki 8892912, Japan
[3] Natl Inst Crop Sci, Dept Field Crop Res, Tsukuba, Ibaraki 3058518, Japan
来源
关键词
sesame; fatty acid oxidation; fatty acid synthesis; lipoprotein production; rat;
D O I
10.6090/jarq.37.151
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Effect of sesamin, a sesame lignan, on the hepatic fatty acid metabolism was examined in the rat. Increase of the dietary level of sesamin progressively increased the mitochondrial and peroxisomal fatty acid oxidation rate. Mitochondrial activity almost doubled in rats fed a 0.5% sesamin diet. Peroxisomal activity became more than 10 times higher in rats fed a 0.5% sesamin diet, compared to those fed a sesamin-free diet. Dietary sesamin also markedly increased the hepatic activity and mRNA levels of various fatty acid oxidation enzymes. In contrast, dietary sesamin decreased the hepatic activity and mRNA abundance of lipogenic enzymes. This was associated with the down-regulation of sterol regulatory element-binding protein-1, a transcriptional factor that regulates the lipogenic enzyme gene expression. Dietary sesamin significantly decreased the triacylglycerol secretion accompanying the increase in ketone body production by the perfused rat liver. It is apparent that sesamin affects the fatty acid metabolism and lipoprotein production in the liver, and hence lowers the serum lipid levels. We also developed several sesame lines with seeds containing sesamin and sesamolin at twice the concentration of conventional cultivars. Compared to a conventional cultivar, these lignan-rich sesame seeds increased the hepatic fatty acid oxidation rate and lowered the serum triacylglycerol level in the rat. Therefore, it is considered that enrichment of the lignans potentiates the characteristics of sesame in improving human health.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [1] Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat
    Ashakumary, L
    Rouyer, I
    Takahashi, Y
    Ide, T
    Fukuda, N
    Aoyama, T
    Hashimoto, T
    Mizugaki, M
    Sugano, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (10): : 1303 - 1313
  • [2] KETOCONAZOLE - A POTENT LIPID-LOWERING AGENT
    BEER, N
    JAKUBOVITZ, D
    TORTOLEDO, F
    ARTERIOSCLEROSIS, 1989, 9 (05): : A726 - A726
  • [3] SCAP ligands are potent new lipid-lowering drugs
    Grand-Perret, T
    Bouillot, A
    Perrot, A
    Commans, S
    Walker, M
    Issandou, M
    NATURE MEDICINE, 2001, 7 (12) : 1332 - 1338
  • [4] SCAP ligands are potent new lipid-lowering drugs
    Thierry Grand-Perret
    Anne Bouillot
    Aurélie Perrot
    Stéphane Commans
    Max Walker
    Marc Issandou
    Nature Medicine, 2001, 7 : 1332 - 1338
  • [5] SERUM LIPID-LOWERING EFFECT OF VINCA ALKALOIDS
    KREMMER, T
    HOLCZINGER, L
    SOMFAIRELLE, S
    BIOCHEMICAL PHARMACOLOGY, 1979, 28 (02) : 227 - 230
  • [6] Serum triglycerides and clinical benefit in lipid-lowering trials
    Kesaniemi, YA
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A): : 70B - 73B
  • [7] Drug interactions with colesevelam hydrochloride, a novel, potent lipid-lowering agent
    Donovan, JM
    Stypinski, D
    Stiles, MR
    Olson, TA
    Burke, SK
    CARDIOVASCULAR DRUGS AND THERAPY, 2000, 14 (06) : 681 - 690
  • [8] Drug Interactions with Colesevelam Hydrochloride, a Novel, Potent Lipid-Lowering Agent
    Joanne M. Donovan
    Daria Stypinski
    Mark R. Stiles
    Timothy A. Olson
    Steven K. Burke
    Cardiovascular Drugs and Therapy, 2000, 14 : 681 - 690
  • [9] Serum lipids, lipid-lowering drugs, and the risk of breast cancer
    Eliassen, AH
    Colditz, GA
    Rosner, B
    Willett, WC
    Hankinson, SE
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (19) : 2264 - 2271
  • [10] LIPOPROTEIN LP(A) VALUES IN SERUM AFTER A LIPID-LOWERING DIET
    MERTZ, DP
    THUILOT, G
    MEDIZINISCHE KLINIK, 1985, 80 (02) : 48 - 52